Evidence for Viral mRNA Export from Ebola Virus Inclusion Bodies by the Nuclear RNA Export Factor NXF1.
Ebola virus
Junin virus
Lloviu virus
NXF1
filovirus
inclusion body
mRNA export
replication factory
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
28 09 2022
28 09 2022
Historique:
pubmed:
31
8
2022
medline:
1
10
2022
entrez:
30
8
2022
Statut:
ppublish
Résumé
Many negative-sense RNA viruses, including the highly pathogenic Ebola virus (EBOV), use cytoplasmic inclusion bodies (IBs) for viral RNA synthesis. However, it remains unclear how viral mRNAs are exported from these IBs for subsequent translation. We recently demonstrated that the nuclear RNA export factor 1 (NXF1) is involved in a late step in viral protein expression, i.e., downstream of viral mRNA transcription, and proposed it to be involved in this mRNA export process. We now provide further evidence for this function by showing that NXF1 is not required for translation of viral mRNAs, thus pinpointing its function to a step between mRNA transcription and translation. We further show that RNA binding of both NXF1 and EBOV NP is necessary for export of NXF1 from IBs, supporting a model in which NP hands viral mRNA over to NXF1 for export. Mapping of NP-NXF1 interactions allowed refinement of this model, revealing two separate interaction sites, one of them directly involving the RNA binding cleft of NP, even though these interactions are RNA-independent. Immunofluorescence analyses demonstrated that individual NXF1 domains are sufficient for its recruitment into IBs, and complementation assays helped to define NXF1 domains important for its function in the EBOV life cycle. Finally, we show that NXF1 is also required for protein expression of other viruses that replicate in cytoplasmic IBs, including Lloviu and Junín virus. These data suggest a role for NXF1 in viral mRNA export from IBs for various viruses, making it a potential target for broadly active antivirals.
Identifiants
pubmed: 36040180
doi: 10.1128/jvi.00900-22
pmc: PMC9517727
doi:
Substances chimiques
Antiviral Agents
0
NXF1 protein, human
0
Nucleocytoplasmic Transport Proteins
0
RNA, Messenger
0
RNA, Viral
0
RNA-Binding Proteins
0
Viral Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0090022Références
Cells. 2020 Jan 11;9(1):
pubmed: 31940815
Virus Res. 2009 Mar;140(1-2):8-14
pubmed: 19041915
J Virol. 2019 Oct 15;93(21):
pubmed: 31375591
Genome Med. 2018 Aug 7;10(1):58
pubmed: 30081931
Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1853-8
pubmed: 17267598
Virology. 1998 Sep 30;249(2):406-17
pubmed: 9791031
J Virol. 2007 Apr;81(7):3554-62
pubmed: 17229682
Cell. 2018 Dec 13;175(7):1917-1930.e13
pubmed: 30550789
Cells. 2020 May 01;9(5):
pubmed: 32370067
J Virol. 2022 Jul 13;96(13):e0059922
pubmed: 35695578
Nat Rev Mol Cell Biol. 2007 Oct;8(10):761-73
pubmed: 17786152
J Gen Virol. 2010 Jun;91(Pt 6):1478-83
pubmed: 20164259
Virology. 2017 Dec;512:39-47
pubmed: 28915404
Virus Res. 2021 Sep;302:198444
pubmed: 33961898
Antiviral Res. 2021 Aug;192:105120
pubmed: 34126139
Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5154-9
pubmed: 18364396
Biochem J. 2016 Oct 1;473(19):2911-35
pubmed: 27679854
PLoS Pathog. 2011 Oct;7(10):e1002304
pubmed: 22039362
Virology. 2010 Jul 20;403(1):56-66
pubmed: 20444481
RNA. 2000 Jan;6(1):136-58
pubmed: 10668806
J Biol Chem. 2019 May 3;294(18):7115-7127
pubmed: 30045872
Nature. 2018 Nov;563(7729):137-140
pubmed: 30333622
J Virol. 2006 Apr;80(8):3743-51
pubmed: 16571791
Nat Commun. 2012;3:1006
pubmed: 22893130
J Virol. 1999 Mar;73(3):2333-42
pubmed: 9971816
J Gen Virol. 2019 May;100(5):760-772
pubmed: 31017565
mBio. 2020 Feb 25;11(1):
pubmed: 32098814
J Virol. 2013 Jul;87(14):8205-12
pubmed: 23698297
Nucleic Acids Res. 2010 Jun;38(10):3351-61
pubmed: 20129943
Nat Rev Dis Primers. 2020 Feb 20;6(1):13
pubmed: 32080199
Antiviral Res. 2018 Sep;157:140-150
pubmed: 30031760
Mol Cell. 2018 Jan 4;69(1):136-145.e6
pubmed: 29290611
Int J Biol Macromol. 2021 Dec 1;192:55-63
pubmed: 34606793
Virus Res. 1995 Dec;39(2-3):129-50
pubmed: 8837880
Mol Cell. 1998 Apr;1(5):649-59
pubmed: 9660949
Nature. 2002 May 16;417(6886):304-8
pubmed: 11979277
Nature. 2001 Oct 11;413(6856):644-7
pubmed: 11675789
Drugs. 2021 Jan;81(1):175-178
pubmed: 33432551
PLoS Pathog. 2011 Jul;7(7):e1002138
pubmed: 21814512
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4275-80
pubmed: 22371572
Nat Commun. 2017 Jul 5;8(1):58
pubmed: 28680096
Sci Rep. 2018 Oct 9;8(1):15005
pubmed: 30301920
RNA. 2007 May;13(5):731-6
pubmed: 17400818
Cell Rep. 2015 Apr 21;11(3):376-89
pubmed: 25865894
Emerg Microbes Infect. 2019;8(1):1347-1360
pubmed: 31516086
EMBO J. 1999 May 4;18(9):2593-609
pubmed: 10228171
Mol Cell. 2001 Sep;8(3):645-56
pubmed: 11583626
J Virol. 2002 Dec;76(24):12877-89
pubmed: 12438613
J Virol. 2012 Nov;86(21):11779-88
pubmed: 22915810
EMBO J. 2021 Sep 15;40(18):e105658
pubmed: 34260076
J Biol Chem. 2014 Aug 15;289(33):22723-22738
pubmed: 24936058
J Virol. 2012 Oct;86(20):11301-10
pubmed: 22875974
J Virol. 2020 Jul 30;94(16):
pubmed: 32493824